Uniogen is a global pioneer in clinical diagnostics, point-of-care testing, and instrumentation for life sciences. Our mission is to enable diagnosis and care for patients at the first appointment. We offer healthcare providers and patients faster, easier, and more cost-effective diagnostics by using advanced technologies.

With our unique point-of-care tests, we provide diagnostics for infectious diseases, cardiovascular diseases, and cancer, among others. GenomEra rapid PCR tests for SARS-CoV-2 / COVID-19 form a significant part of our current business. Additionally, we provide laboratory instruments and tests for the detection of anti-SARS-CoV-2 antibodies and other diseases through contract development and manufacturing services.

Our Upcon® labeling system, coupled with state-of-the-art laboratory instruments and flexible software, ensures high sensitivity and superior performance in point-of-care testing. Uniogen was established when Abacus Diagnostica, Kaivogen, and Labrox joined forces. Headquartered in Turku, Finland, we employ close to 100 life science professionals and sell our products in approximately 100 countries worldwide.

Join us in our mission to bring faster and more accurate diagnostics to patients globally. For more information, please contact us